News Room

Company Remains on Schedule for PMA Submission to FDA White Bear Lake, Minnesota--(Newsfile Corp. - ...

Received FDA approval to expand fully implanted Acclaim® Cochlear Implant Pivotal Clinical Trial to ...

First Cochlear Implant Company to Announce Completed Enrollment of a U.S. Pivotal Clinical Trial for...

White Bear Lake, Minnesota--(Newsfile Corp. - February 24, 2026) - Envoy Medical® Inc. (NASDAQ: COCH...

White Bear Lake, Minnesota--(Newsfile Corp. - February 23, 2026) - Envoy Medical® Inc. (NASDAQ: COCH...

Financing was led by new investor and top-tier healthcare fund Nantahala Capital and longtime Envoy ...

45 of 56 Patients Implanted; Enrollment Completion Anticipated by End of March

$30.0 million upfront with up to an additional $48.0 million of potential aggregate gross proceeds u...

Enrollment momentum accelerates as Company advances toward full enrollment

Patent strengthens Company's global intellectual property portfolio and reinforces the Company's com...